专家共识 第37页
排序
诊疗推荐方案解读-2333a7e277-pptx-1.webp)
儿科感染性休克(脓毒性休克)诊疗推荐方案解读
儿科感染性休克（脓毒性休克)诊疗推荐方案-概况中华医学会儿科学分会急救学组制定正式公布、发表于2006年8月。中华儿科杂志中华急诊医学杂志同时发表中国小儿急救医学
2个月前
![2023NICE技术鉴定指导意见：派姆单抗联合化疗联合或不联合贝伐单抗治疗持续性、复发性或转移性宫颈癌[TA885]-医知素材库](https://cdn.jiaoyuwz.com/2023NICE技术鉴定指导意见：派姆单抗联合化疗联合或不联合贝伐单抗治疗持续性、复发性或转移性宫颈癌[TA885]-b59502e641-pdf-1.webp)
2023NICE技术鉴定指导意见：派姆单抗联合化疗联合或不联合贝伐单抗治疗持续性、复发性或转移性宫颈癌[TA885]
NENatonalinsutute forHealth and Care ExcellenceNICE贝guidancePembrolizumab pluschemotherapy with orwithout bevacizumab forpersistent,recurrent ormetastatic cervical cancerTechnolog...
![2023NICE指南：早期和局部晚期乳腺癌的诊断和治疗[NG101]-医知素材库](https://cdn.jiaoyuwz.com/2023NICE指南：早期和局部晚期乳腺癌的诊断和治疗[NG101]-f2cbe88cce-pdf-1.webp)
2023NICE指南：早期和局部晚期乳腺癌的诊断和治疗[NG101]
NICENational Institute forHealth and Care ExcellenceNICE贝guidelineEarly and locally advancedbreast cancer:diagnosisand managementNICE guidelinePublished:18 July 2018www.nice.org.u...
2023SNIS指南：神经介入手术中的抗血小板和抗血栓药物管理（更新版）
StandardsAntiplatelets and antithrombotics inneurointerventional procedures:Guideline updateClemens M Schirmer,Ketan R Bulsara,2 Fawaz Al-Mufti3 Neil HaranhalliNeurolnterventLucie ...
2023澳大利亚和新西兰共识指南：儿童新诊断免疫性血小板减少症
Journal of Paediatrics andChild Healthdot10.1111Ujpc.16395POSITION PAPERAustralian and New Zealand consensus guideline for paediatricnewly diagnosed immune thrombocytopaenia endors...
2023共识声明：代谢性高铁蛋白血症的定义和分类
nature reviews endocrinologyhttps:/doi.org/10.1038/s41574-023-00807-6Consensus statementCheck for updatesConsensus Statement on thedefinition and classification ofmetabolic hyperfe...
2023临床指南：晚期慢性肝病患者的围术期管理
lifeMDPIReviewClinical Guideline on Perioperative Management of Patientswith Advanced Chronic Liver DiseaseLidia Canillas 1,2,3,Amalia Pelegrina 1,3,4,Juan Alvarez 3,5,Elena Colomi...
2023循证指南：嗜酸性肉芽肿性多血管炎的诊断和管理
nature reviews rheumatologyhttps:/doi.org/10.1038/s41584-023-00958-wEvidence-based guidelinesCheck for updatesEvidence-Based Guideline forthe diagnosis and managementofeosinophilic...
2023专家共识声明：布罗利尤单抗治疗中重度银屑病
Journal ofClinical MedicineMDPIArticleBrodalumab for the Treatment of Moderate-to-Severe Psoriasis:An Expert Delphi Consensus StatementMaria Concetta Fargnoli Federico BardazziLuca...
